CYP2C9 Genetic Polymorphism is a Potential Predictive Marker for the Efficacy of Rosuvastatin Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CYP2C9 Genetic Polymorphism is a Potential Predictive Marker for the Efficacy of Rosuvastatin Therapy

Published:2015 Issue:09/2015 Volume:61 Page:
ISSN:1433-6510
Container-title:Clinical Laboratory
language:en
Short-container-title:Clin. Lab.

Author:

Lin Jiayao,Zhang Yu,Zhou Houguang,Wang Xinqing,Wang Wenwen

Publisher

Clinical Laboratory Publications

Subject

General Biochemistry, Genetics and Molecular Biology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of gut microbiota and metabolomics in the lipid-lowering efficacy of statins among Chinese patients with coronary heart disease and hypercholesterolemia;Frontiers in Cellular and Infection Microbiology;2024-07-25

2. Pharmacogenomic variants affecting efficacy and toxicity of statins in a south Asian population from Sri Lanka;Pharmacogenomics;2023-10

3. Pharmacogenomics of response to statin treatment and susceptibility to statin-induced adverse drug reactions in Asians: a scoping review;Asian Biomedicine;2023-06-01

4. Pharmacogenomics of lipid-lowering agents: the impact on efficacy and safety;Personalized Medicine;2022-11-23

5. Association of ABCB1 polymorphisms with lipid homeostasis and liver injury response to atorvastatin in the Chinese population;Canadian Journal of Physiology and Pharmacology;2020-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP